Patents by Inventor Michael J. Rice

Michael J. Rice has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210323962
    Abstract: Imidazo[4,5-c]quinoline compounds having a substituent that is attached at the N?1 position by a branched group, single enantiomers of the compounds, pharmaceutical compositions containing the compounds, and methods of making the compounds are disclosed. Methods of use of the compounds as immune response modifiers, for inducing cytokine biosynthesis in humans and animals, and in the treatment of diseases including infectious and neoplastic diseases are also disclosed.
    Type: Application
    Filed: November 11, 2019
    Publication date: October 21, 2021
    Inventors: George W. Griesgraber, Bryon A. Merrill, Michael J. Rice
  • Publication number: 20210289878
    Abstract: An article of footwear includes an upper member and a sole structure, with a sensor system connected to the sole structure. The sensor system includes a plurality of sensors that are configured for detecting forces exerted by a user's foot on the sensor. The sensor system also includes a port that is configured to receive a module to place the module in communication with the sensors. The port includes a housing with a chamber configured to receive the module and an interface engaged with the housing and having at least one electrical contact exposed to the chamber. Additional retaining structure and interface structure may be included.
    Type: Application
    Filed: June 7, 2021
    Publication date: September 23, 2021
    Inventors: James Molyneux, Aaron B. Weast, Jordan M. Rice, Allan M. Schrock, Michael S. Amos, Andrew A. Owings, Martine Stillman, Joseph B. Horrell, Jonathan B. Knight, Dane R. Weitmann, Jeffrey J. Hebert
  • Patent number: 10557069
    Abstract: A working fluid that includes a fluorinated olefin compound represented by the following general formula (I):
    Type: Grant
    Filed: March 4, 2019
    Date of Patent: February 11, 2020
    Assignee: 3M Innovative Properties Company
    Inventors: Michael J. Bulinski, Michael G. Costello, John G. Owens, Michael J. Rice
  • Publication number: 20190225852
    Abstract: A working fluid that includes a fluorinated olefin compound represented by the following general formula (I):
    Type: Application
    Filed: March 4, 2019
    Publication date: July 25, 2019
    Inventors: Michael J. Bulinski, Michael G. Costello, John G. Owens, Michael J. Rice
  • Patent number: 10280351
    Abstract: A working fluid that includes a fluorinated olefin compound represented by the following general formula (I):
    Type: Grant
    Filed: March 20, 2018
    Date of Patent: May 7, 2019
    Assignee: 3M INNOVATIVE PROPERTIES COMPANY
    Inventors: Michael J. Bulinski, Michael G. Costello, John G. Owens, Michael J. Rice
  • Publication number: 20180320040
    Abstract: A working fluid that includes a fluorinated olefin compound represented by the following general formula (I):
    Type: Application
    Filed: March 20, 2018
    Publication date: November 8, 2018
    Inventors: Michael J. Bulinski, Michael G. Costello, John G. Owens, Michael J. Rice
  • Patent number: 9957428
    Abstract: A working fluid that includes a fluorinated olefin compound represented by the following general formula (I). In some embodiments, an apparatus for heat transfer is provided. The apparatus includes a device and a mechanism for transferring heat to or from the device. In some embodiments, a fire extinguishing composition is provided. In some embodiments, an apparatus for converting thermal energy into mechanical energy in a Rankine cycle is provided.
    Type: Grant
    Filed: December 17, 2014
    Date of Patent: May 1, 2018
    Assignee: 3M INNOVATIVE PROPERTIES COMPANY
    Inventors: Michael J. Bulinski, Michael G Costello, John G. Owens, Michael J. Rice
  • Publication number: 20180057509
    Abstract: Thiazoloquinolines and thiazolonaphthyridines with an alkoxy substituent at the 6, 7, 8, or 9-position, pharmaceutical compositions containing the compounds, intermediates, methods of making and methods of use of these compounds as immunomodulators, for inducing cytokine biosynthesis in animals and in the treatment of diseases including viral and neoplastic diseases are disclosed.
    Type: Application
    Filed: November 2, 2017
    Publication date: March 1, 2018
    Inventors: RYAN B. PRINCE, BRYON A. MERRILL, PHILIP D. HEPPNER, TUSHAR A. KSHIRSAGAR, JOSHUA R. WURST, KARL J. MANSKE, MICHAEL J. RICE
  • Patent number: 9856254
    Abstract: Imidazoquinoline compounds with an alkoxy substituent at the 6, 7, 8, or 9-position, pharmaceutical compositions containing the compounds, intermediates, methods of making, and methods of use of these compounds as immunomodulators, for inducing or inhibiting cytokine biosynthesis in animals and in the treatment of diseases including viral, and neoplastic, are disclosed.
    Type: Grant
    Filed: June 13, 2016
    Date of Patent: January 2, 2018
    Assignee: 3M Innovative Properties Company
    Inventors: Kyle J. Lindstrom, Bryon A. Merrill, Chad A. Haraldson, Michael J. Rice, Tushar A. Kshirsagar, Philip D. Heppner, Joshua R. Wurst, Shri Niwas, Sarah J. Slania
  • Publication number: 20170088559
    Abstract: Thiazoloquinolines and thiazolonaphthyridines with an alkoxy substituent at the 6, 7, 8, or 9-position, pharmaceutical compositions containing the compounds, intermediates, methods of making and methods of use of these compounds as immunomodulators, for inducing cytokine biosynthesis in animals and in the treatment of diseases including viral and neoplastic diseases are disclosed.
    Type: Application
    Filed: December 12, 2016
    Publication date: March 30, 2017
    Inventors: RYAN B. PRINCE, BRYON A. MERRILL, PHILIP D. HEPPNER, TUSHAR A. KSHIRSAGAR, JOSHUA R. WURST, KARL J. MANSKE, MICHAEL J. RICE
  • Patent number: 9546184
    Abstract: Thiazoloquinolines and thiazolonaphthyridines with an alkoxy substituent at the 6, 7, 8, or 9-position, pharmaceutical compositions containing the compounds, intermediates, methods of making and methods of use of these compounds as immunomodulators, for inducing cytokine biosynthesis in animals and in the treatment of diseases including viral and neoplastic diseases are disclosed.
    Type: Grant
    Filed: June 8, 2015
    Date of Patent: January 17, 2017
    Assignee: 3M INNOVATIVE PROPERTIES COMPANY
    Inventors: Ryan B. Prince, Bryon A. Merrill, Philip D. Heppner, Tushar A. Kshirsagar, Joshua R. Wurst, Karl J. Manske, Michael J. Rice
  • Publication number: 20160280707
    Abstract: Imidazoquinoline compounds with an alkoxy substituent at the 6, 7, 8, or 9-position, pharmaceutical compositions containing the compounds, intermediates, methods of making, and methods of use of these compounds as immunomodulators, for inducing or inhibiting cytokine biosynthesis in animals and in the treatment of diseases including viral, and neoplastic, are disclosed.
    Type: Application
    Filed: June 13, 2016
    Publication date: September 29, 2016
    Inventors: Kyle J. Lindstrom, Bryon A. Merrill, Chad A. Haraldson, Michael J. Rice, Tushar A. Kshirsagar, Philip D. Heppner, Joshua R. Wurst, Shri Niwas, Sarah J. Slania
  • Patent number: 9365567
    Abstract: Imidazoquinoline compounds with an alkoxy substituent at the 6, 7, 8, or 9-position, pharmaceutical compositions containing the compounds, intermediates, methods of making, and methods of use of these compounds as immunomodulators, for inducing or inhibiting cytokine biosynthesis in animals and in the treatment of diseases including viral, and neoplastic, are disclosed.
    Type: Grant
    Filed: September 30, 2014
    Date of Patent: June 14, 2016
    Assignee: 3M Innovative Properties Company
    Inventors: Kyle J. Lindstrom, Bryon A. Merrill, Chad A. Haraldson, Michael J. Rice, Tushar A. Kshirsagar, Philip D. Heppner, Joshua R. Wurst, Shri Niwas, Sarah J. Slania
  • Publication number: 20150266901
    Abstract: Thiazoloquinolines and thiazolonaphthyridines with an alkoxy substituent at the 6, 7, 8, or 9-position, pharmaceutical compositions containing the compounds, intermediates, methods of making and methods of use of these compounds as immunomodulators, for inducing cytokine biosynthesis in animals and in the treatment of diseases including viral and neoplastic diseases are disclosed.
    Type: Application
    Filed: June 8, 2015
    Publication date: September 24, 2015
    Inventors: RYAN B. PRINCE, BRYON A. MERRILL, PHILIP D. HEPPNER, TUSHAR A. KSHIRSAGAR, JOSHUA R. WURST, KARL J. MANSKE, MICHAEL J. RICE
  • Publication number: 20150023990
    Abstract: Imidazoquinoline compounds with an alkoxy substituent at the 6, 7, 8, or 9-position, pharmaceutical compositions containing the compounds, intermediates, methods of making, and methods of use of these compounds as immunomodulators, for inducing or inhibiting cytokine biosynthesis in animals and in the treatment of diseases including viral, and neoplastic, are disclosed.
    Type: Application
    Filed: September 30, 2014
    Publication date: January 22, 2015
    Inventors: Kyle J. Lindstrom, Bryon A. Merrill, Chad A. Haraldson, Michael J. Rice, Tushar A. Kshirsagar, Philip D. Heppner, Joshua R. Wurst, Shri Niwas, Sarah J. Slania
  • Patent number: 8871782
    Abstract: Imidazoquinoline compounds with an alkoxy substituent at the 6, 7, 8, or 9-position, pharmaceutical compositions containing the compounds, intermediates, methods of making, and methods of use of these compounds as immunomodulators, for inducing or inhibiting cytokine biosynthesis in animals and in the treatment of diseases including viral, and neoplastic, are disclosed.
    Type: Grant
    Filed: October 1, 2004
    Date of Patent: October 28, 2014
    Assignee: 3M Innovative Properties Company
    Inventors: Kyle J. Lindstrom, Bryon A. Merrill, Chad A. Haraldson, Michael J. Rice, Tushar A. Kshirsagar, Philip D. Heppner, Joshua R. Wurst, Shri Niwas, Sarah C. Johannessen
  • Patent number: 8658666
    Abstract: Imidazoquinolines and imidazonaphthyridines with a substituent containing a functional group, e.g., an amide, sulfonamide, urea, or heterocyclyl group, at the 6, 7, 8, or 9-position, pharmaceutical compositions containing the compounds, intermediates, methods of making and methods of use of these compounds as immunomodulators, for inducing cytokine biosynthesis in animals and in the treatment of diseases including viral and neoplastic diseases are disclosed.
    Type: Grant
    Filed: February 10, 2006
    Date of Patent: February 25, 2014
    Assignee: 3M Innovative Properties Company
    Inventors: Michael J. Rice, Chad A. Haraldson, John F. Gerster, Joshua R. Wurst, Philip D. Heppner, Bryon A. Merrill, Tushar A. Kshirsagar
  • Patent number: 8546383
    Abstract: Fused [1,2]imidazo[4,5-c] ring compounds (e.g., imidazo[4,5-c]quinolines, 6,7,8,9-tetrahydroimidazo[4,5-c]quinolines, imidazo[4,5-c]naphthyridines, and 6,7,8,9-tetrahydroimidazo[4,5-c]naphthyridines) with a —CH(—X1—R1)— group in the fused ring at the 1-position of the imidazo ring, pharmaceutical compositions containing the compounds, intermediates, methods of making the compounds, and methods of use of these compounds as immunomodulators, for inducing cytokine biosynthesis in animals and in the treatment of diseases including viral and neoplastic diseases, are disclosed.
    Type: Grant
    Filed: May 25, 2012
    Date of Patent: October 1, 2013
    Assignee: 3M Innovative Properties Company
    Inventors: George W. Griesgraber, Tushar A. Kshirsagar, Azim A. Celebi, Sarah J. Slania, Michael E. Danielson, Michael J. Rice, Joshua R. Wurst
  • Publication number: 20120232057
    Abstract: Fused [1,2]imidazo[4,5-c] ring compounds (e.g., imidazo[4,5-c]quinolines, 6,7,8,9-tetrahydroimidazo[4,5-c]quinolines, imidazo[4,5-c]naphthyridines, and 6,7,8,9-tetrahydroimidazo[4,5-c]naphthyridines) with a —CH(—X1—R1)— group in the fused ring at the 1-position of the imidazo ring, pharmaceutical compositions containing the compounds, intermediates, methods of making the compounds, and methods of use of these compounds as immunomodulators, for inducing cytokine biosynthesis in animals and in the treatment of diseases including viral and neoplastic diseases, are disclosed.
    Type: Application
    Filed: May 25, 2012
    Publication date: September 13, 2012
    Inventors: George W. GRIESGRABER, Tushar A. KSHIRSAGAR, Azim A. CELEBI, Sarah J. SLANIA, Michael E. DANIELSON, Michael J. RICE, Joshua R. WURST
  • Patent number: 8263594
    Abstract: Imidazoquinoline compounds with an aryloxy or arylalkyleneoxy substituent at the 6, 7, 8, or 9-position, pharmaceutical compositions containing the compounds, intermediates, and methods of use of these compounds as immunomodulators, for modulating cytokine biosynthesis in animals and in the treatment of diseases including viral and neoplastic diseases, are disclosed.
    Type: Grant
    Filed: January 18, 2011
    Date of Patent: September 11, 2012
    Assignee: 3M Innovative Properties Company
    Inventors: Kyle J. Lindstrom, Hugues M. H. Martin, Bryon A. Merrill, Michael J. Rice, Joshua R. Wurst, Chad A. Haraldson, Philip D. Heppner, Shri Niwas, Matthew R. Radmer